Broadfin Capital, LLC - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,568,000
+103.9%
1,888,039
+16.5%
0.48%
+47.5%
Q3 2019$1,750,000
-85.6%
1,620,000
-20.2%
0.32%
-87.1%
Q1 2019$12,165,000
-12.3%
2,030,925
+8.2%
2.51%
+37.7%
Q4 2018$13,875,0001,877,5021.82%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,858,569$85,243,00025.08%
Sofinnova Management VIII, L.L.C. 1,539,480$45,907,00024.21%
EcoR1 Capital, LLC 673,100$20,072,0005.07%
Cormorant Asset Management, LP 800,000$23,856,0003.46%
Perceptive Advisors 1,260,847$37,598,0002.14%
NEXTHERA CAPITAL LP 111,500$3,325,0001.70%
Foresite Capital Management III, LLC 140,000$4,175,0001.60%
ACUTA CAPITAL PARTNERS, LLC 200,000$5,964,0001.41%
Rock Springs Capital Management LP 675,000$20,129,0001.16%
CAXTON CORP 13,263$395,0001.13%
View complete list of ACLARIS THERAPEUTICS INC shareholders